pCONUS2 Treatment of Wide Neck Intracranial Aneurysms 2
NCT03273478 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-04-05
Summary
To assess safety and efficacy of pCONUS2 for the treatment of wide neck bifurcation aneurysms.
Conditions
- Intracranial Aneurysm
Interventions
- DEVICE
-
Endovascular treatment of bifurcation aneurysm with pCONUS2
Patients suffering from a bifurcation aneurysm will be treated endovascularly with the pCONUS2 device. * The patients do not face any additional risks by participating in the study as the treatment does not differ from the standard of care in any way. * The patients will only be enrolled in the study if they give their written consent. * If they do not wish to participate in the observational study or if they wish to withdraw from it at a later date, they will not have any disadvantages.
Sponsors & Collaborators
-
Phenox GmbH
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-31
- Primary Completion
- 2020-12-31
- Completion
- 2021-12-31
More Related Trials
-
A Study of GLWL-01 in Patients With Prader-Willi Syndrome
NCT03274856 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Metformin in Individuals With Fragile X Syndrome
NCT03479476 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease
NCT03687476 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy
NCT00973011 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
NCT05485987 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability, and Efficacy Study of BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease
NCT02678689 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
NCT05515536 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Metformin in Children and Adults With Fragile X Syndrome
NCT03722290 ·Status: COMPLETED ·Phase: PHASE2
-
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor
NCT02678533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
NCT06147856 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome
NCT01253629 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
NCT03614663 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
NCT05358886 ·Status: COMPLETED ·Phase: PHASE3
-
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
NCT00053937 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome
NCT04977986 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
NCT03714373 ·Status: COMPLETED ·Phase: PHASE3
-
N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC)
NCT03759639 ·Status: COMPLETED ·Phase: PHASE2
-
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS
NCT07156214 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria
NCT04534842 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease
NCT01907087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
NCT01212744 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
NCT03862950 ·Status: COMPLETED ·Phase: PHASE2
-
Study of SPG601 in Adult Men With Fragile X Syndrome
NCT06413537 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
NCT01275586 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Decisional Capacity and Informed Consent in Fragile X Syndrome
NCT02465931 ·Status: COMPLETED ·Phase: NA